The ameliorating effects of Guizhi Fuling Wan combined with rosiglitazone in a rat ovarian model of polycystic ovary syndrome by the PI3K/AKT/NF-κB and Nrf2/HO-1 pathways

References

• Li X, Fang Z, Yang X, et al. The effect of metformin on homocysteine levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis. J Obstet Gynaecol Res. 2021;47(5):1–12. doi: 10.1111/jog.14725.
   Web of Science ®Google Scholar
• Stener-Victorin E, Padmanabhan V, Walters KA, et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev. 2020;41(4):bnaa010.
   PubMed Web of Science ®Google Scholar
• Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132(2):321–336. doi: 10.1097/AOG.0000000000002698.
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Siscovick D, Merkin SS, et al. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the coronary artery risk development in young adults women’s study. Arterioscler Thromb Vasc Biol. 2014;34(12):2688–2694. doi: 10.1161/ATVBAHA.114.304136.
   PubMed Web of Science ®Google Scholar
• Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36. doi: 10.1016/j.jsbmb.2018.04.008.
   PubMed Web of Science ®Google Scholar
• Rothenberg SS, Beverley R, Barnard E, et al. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018;48:103–114. doi: 10.1016/j.bpobgyn.2017.08.008.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang C, Huang Y, et al. Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-κB signaling in the granulosa cells of PCOS patients. J Clin Endocrinol Metab. 2015;100(1):201–211. doi: 10.1210/jc.2014-2419.
   PubMed Web of Science ®Google Scholar
• Ji R, Jia F, Chen X, et al. Carnosol inhibits KGN cells oxidative stress and apoptosis and attenuates polycystic ovary syndrome phenotypes in mice through Keap1-mediated Nrf2/HO-1 activation. Phytother Res. 2023;37(4):1405–1421. doi: 10.1002/ptr.7749.
   PubMed Web of Science ®Google Scholar
• Wang R, Li W, Bordewijk EM, et al. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis. Hum Reprod Update. 2019;25(6):717–732. doi: 10.1093/humupd/dmz029.
   PubMed Web of Science ®Google Scholar
• Bordewijk EM, et al. Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;2(2):Cd001122.
   PubMedGoogle Scholar
• Ong M, Peng J, Jin X, et al. Chinese herbal medicine for the optimal management of polycystic ovary syndrome. Am J Chin Med. 2017;45(3):405–422. doi: 10.1142/S0192415X17500252.
   PubMed Web of Science ®Google Scholar
• Meng W, Ta N, Wang F. Add-on effect of guizhi fuling formula to mifepristone for endometriosis: a meta-analysis of randomized controlled trials. Medicine. 2019;98(33):e16878. doi: 10.1097/MD.0000000000016878.
   PubMed Web of Science ®Google Scholar
• Tao LTA, Liu M. Effect of guizhifu ling pill combined with berberine on patients with polycystic ovary syndrome with insulin resistance. Chin J Exp Tradit Med Formulae. 2013;19:320–323.
   Google Scholar
• Wu JDH, Liu Y . Clinical research progress of guizhi fuling wan in the treatment of infertility. J Guangzhou Univ Tradit Chin Med. 2020;37:586–590.
   Google Scholar
• Liu M, Zhu H, Zhu Y, et al. Guizhi fuling wan reduces autophagy of granulosa cell in rats with polycystic ovary syndrome via restoring the PI3K/AKT/mTOR signaling pathway. J Ethnopharmacol. 2021;270:113821. doi: 10.1016/j.jep.2021.113821.
   PubMed Web of Science ®Google Scholar
• Wu P, Zhu Y, Li J, et al. Guizhi fuling wan inhibits autophagy of granulosa cells in polycystic ovary syndrome mice via H19/miR-29b-3p. Gynecol Endocrinol. 2023;39(1):2210232.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li Y, Liu M, et al. Guizhi fuling wan, Chinese herbal medicine, ameliorates insulin sensitivity in PCOS model rats with insulin resistance via remodeling intestinal homeostasis. Front Endocrinol. 2020;11:575. doi: 10.3389/fendo.2020.00575.
   PubMed Web of Science ®Google Scholar
• Li Y-C, Qiao J-Y, Wang B-Y, et al. Paeoniflorin ameliorates fructose-induced insulin resistance and hepatic steatosis by activating LKB1/AMPK and AKT pathways. Nutrients. 2018;10(8):1024. doi: 10.3390/nu10081024.
   PubMed Web of Science ®Google Scholar
• Ma Z, Liu H, Wang W, et al. Paeoniflorin suppresses lipid accumulation and alleviates insulin resistance by regulating the rho kinase/IRS-1 pathway in palmitate-induced HepG2Cells. Biomed Pharmacother. 2017;90:361–367. doi: 10.1016/j.biopha.2017.03.087.
   PubMed Web of Science ®Google Scholar
• Stout D, Fugate S. Thiazolidinediones for treatment of polycystic ovary syndrome. Pharmacotherapy. 2005;25(2):244–252. doi: 10.1592/phco.25.2.244.56943.
   PubMed Web of Science ®Google Scholar
• Li Y, Tan J, Wang Q, et al. Comparing the individual effects of metformin and rosiglitazone and their combination in obese women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril. 2020;113(1):197–204. doi: 10.1016/j.fertnstert.2019.09.011.
   PubMed Web of Science ®Google Scholar
• Han L, Guo X, Bian H, et al. Guizhi fuling wan, a traditional Chinese herbal formula, sensitizes cisplatin-resistant human ovarian cancer cells through inactivation of the PI3K/AKT/mTOR pathway. Evid Based Complement Alternat Med. 2016. 2016;2016:4651949.
   PubMed Web of Science ®Google Scholar
• National Commission of Chinese Pharmacopoeia. Pharmacopoeia of peoples republic of China. Vol. 1. Beijing: China Medical Science and Technology Press; 2010.
   Google Scholar
• Yu Y, Cao Y, Huang W, et al. β-Sitosterol ameliorates endometrium receptivity in PCOS-Like mice: the mediation of gut microbiota. Front Nutr. 2021;8:667130. doi: 10.3389/fnut.2021.667130.
   PubMed Web of Science ®Google Scholar
• Xu Y, Pan C-S, Li Q, et al. The ameliorating effects of bushen huatan granules and kunling wan on polycystic ovary syndrome induced by dehydroepiandrosterone in rats. Front Physiol. 2021;12:525145. doi: 10.3389/fphys.2021.525145.
   PubMed Web of Science ®Google Scholar
• Singh P, Agress A, Madrigal VK, et al. Massive ovarian growth in a woman with severe Insulin-Resistant polycystic ovary syndrome receiving GnRH analogue. J Clin Endocrinol Metab. 2019;104(7):2796–2800. doi: 10.1210/jc.2018-02464.
   PubMed Web of Science ®Google Scholar
• Wang J, Wu D, Guo H, et al. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci. 2019;236:116940. doi: 10.1016/j.lfs.2019.116940.
   PubMed Web of Science ®Google Scholar
• Zhang B, Wang J, Shen S, et al. Association of androgen excess with glucose intolerance in women with polycystic ovary syndrome. Biomed Res Int. 2018;2018:6869705. doi: 10.1155/2018/6869705.
   PubMed Web of Science ®Google Scholar
• Zhao H, Song X, Zhang L, et al. Comparison of androgen levels, endocrine and metabolic indices, and clinical findings in women with polycystic ovary syndrome in Uygur and Han ethnic groups from Xinjiang province in China. Med Sci Monit. 2018;24:6774–6780. doi: 10.12659/MSM.909715.
   PubMed Web of Science ®Google Scholar
• Paoli A, Mancin L, Giacona MC, et al. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. J Transl Med. 2020;18(1):104. doi: 10.1186/s12967-020-02277-0.
   PubMed Web of Science ®Google Scholar
• Rababa’h AM, Matani BR, Ababneh MA. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats. Life Sci. 2020;261:118353. doi: 10.1016/j.lfs.2020.118353.
   PubMed Web of Science ®Google Scholar
• Lin J, Xu Y, Zhang AH, et al. Effect of guizhi fuling wan combined with Western medicine in the treatment of polycystic ovary syndrome. China’s Health Standards Management. 2019;10:92–94.
   Google Scholar
• Lou XL, Chen Y. Clinical study on treating infertility caused by ovulatory disorder in polycystic ovary syndrome with yulin zhu and guizhi fuling wan. Journal of New Chinese Medicine. 2019;51:43–47.
   Google Scholar
• Kalyan S, Patel MS, Kingwell E, et al. Competing factors link to bone health in polycystic ovary syndrome: chronic low-grade inflammation takes a toll. Sci Rep. 2017;7(1):3432. doi: 10.1038/s41598-017-03685-x.
   PubMedGoogle Scholar
• Milutinović DV, Nikolić M, Veličković N, et al. Enhanced inflammation without impairment of insulin signaling in the visceral adipose tissue of 5α-dihydrotestosterone-induced animal model of polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2017;125(8):522–529. doi: 10.1055/s-0043-104531.
   PubMed Web of Science ®Google Scholar
• Saglam E, Canakci CF, Sebin SO, et al. Evaluation of oxidative status in patients with chronic periodontitis and polycystic ovary syndrome: a cross-sectional study. J Periodontol. 2018;89(1):76–84. doi: 10.1902/jop.2017.170129.
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268–288. doi: 10.1093/humupd/dms059.
   PubMed Web of Science ®Google Scholar
• Artimani T, Karimi J, Mehdizadeh M, et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2018;34(2):148–152. doi: 10.1080/09513590.2017.1371691.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hu M, Meng F, et al. Metformin ameliorates uterine defects in a rat model of polycystic ovary syndrome. EBioMedicine. 2017;18:157–170. doi: 10.1016/j.ebiom.2017.03.023.
   PubMed Web of Science ®Google Scholar
• Xie F, Zhang J, Zhai M, et al. Melatonin ameliorates ovarian dysfunction by regulating autophagy in PCOS via the PI3K-Akt pathway. Reproduction. 2021;162(1):73–82. doi: 10.1530/REP-20-0643.
   PubMed Web of Science ®Google Scholar
• Lei L, Zhao J, Liu X-Q, et al. Wogonin alleviates kidney tubular epithelial injury in diabetic nephropathy by inhibiting PI3K/akt/NF-κB signaling pathways. Drug Des Devel Ther. 2021;15:3131–3150. doi: 10.2147/DDDT.S310882.
   PubMed Web of Science ®Google Scholar
• Zhang S, Lai X, Wang X, et al. Deciphering the pharmacological mechanisms of guizhi-fuling capsule on primary dysmenorrhea through network pharmacology. Front Pharmacol. 2021;12:613104. doi: 10.3389/fphar.2021.613104.
   PubMed Web of Science ®Google Scholar
• Li X, Gu LW, Ran QS, et al. Protective effects of three phenylallyl compounds from guizhi decoction ox-LDL-induced oxidative stress injury of human brain microvascular endothelial cells. Zhongguo Zhong Yao Za Zhi. 2016;41(12):2315–2320.
   PubMedGoogle Scholar
• Liu S, Cao X, Zhang T, et al. Paeonol ameliorates endometrial hyperplasia in mice via inhibiting PI3K/AKT pathway-related ferroptosis. Phytomedicine. 2023;109:154593. doi: 10.1016/j.phymed.2022.154593.
   PubMed Web of Science ®Google Scholar
• Xu B, Zheng J, Tian X, et al. Protective mechanism of traditional Chinese medicine guizhi fuling pills against carbon tetrachloride-induced kidney damage is through inhibiting oxidative stress, inflammation and regulating the intestinal flora. Phytomedicine. 2022;101:154129. doi: 10.1016/j.phymed.2022.154129.
   PubMed Web of Science ®Google Scholar